+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Global Inhaler Market Research and Forecast 2018-2023

  • ID: 4621257
  • Report
  • Region: Global
  • Orion Market Research Private Limited
until Dec 31st 2019
1 of 3


  • 3M
  • Bespak
  • Glaxosmithkline
  • Midascare
  • Propeller Health
  • Teicos Pharma Ltd
  • MORE
Inhaler is a device commonly used as a facilitator in providing medication through lungs of the patients. The medication through lungs is generally provided to prevent or relieve from asthma attacks and other respiratory ailments. The device such as nebulizer is used in hospitals to provide medications more effectively and has least side effects on the patients. The Inhalers are widely used due to its integration with smart technologies. The rising number of smokers, rapidly increasing air pollution and prevalence of pulmonary disease is the driver for the growth of global inhaler market. The use of inhaler for medication has the least side effects and is effective in giving treatment to patients. The devices are widely used in hospitals, clinics and at patient’s facility. The cost considerations related to refilling of the inhaler is the major factor that restrains the market growth, the use of inhalers in some cases is life-long making it difficult for patients to cope up with such long-time frame. The adoption of smart technologies in manufacturing smart inhalers is paving way for future market growth, moreover the increasing trends for miniature devices is also helping the market to grow.

The market is divided into North America, Europe, Asia Pacific and Rest of the World geographically. The North American region leads the market of Inhaler due to the rising cases and prevalence of pulmonary disease, moreover the region also has large number of companies. The European region is second most capturer of global inhaler market because of rapid advancement in technologies, adoption of smart inhaler concept and the presence of large number of companies. The Asia pacific region is expected to grow significantly in the forecasted period due to rapid investments and development in economies like India and China, moreover the region also has high prevalence rate of respiratory disease due to increasing air pollution.

The company engaged in Inhaler market provides a large array of respiratory devices used to deal with ailments pertaining to respiratory diseases. Companies engaged in global inhaler market provides a wide array of nasal inhalers, nebulizers, dry powder inhalers and metered dose inhalers. A large number of companies are engaged in development on smart inhalers to make the devices handier and smarter. The presence of large array of companies in the segment makes the market highly competitive. The prominent players in market are Agilent Technologies, Aradigm Corporation, AstraZeneca Plc, Boehringer Ingelheim GmbH, Drive DeVilbiss Healthcare, GE nebulizer, GlaxoSmithKline, Hovione, Mannkind corporation, Manta Devices LLC, Novartis AG, Omega life sciences, OMRON Healthcare Europe B.V and so on.

Research Methodology:

The market study of Global Inhaler market is incorporated by extensive primary and secondary research. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report country level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings the authenticity in our reports.

Secondary sources include:
  • Financial reports of companies involved in the market
  • Authentic Public Databases (org, gov and other such websites)
  • Whitepapers, research-papers and news blogs
  • Company websites and their product catalogue.
The report is intended for Emerging companies and researchers in the market, Investing companies, Government Organizations for overall market analysis and competitive analysis. The report provides in-depth analysis on market size, growth opportunity in market, product types . The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models such as PEST analysis, Porter five analysis delivering insights into the market for better business decisions.

Market Segmentation:

Global Inhaler Market is segmented on the basis of various regions and below mentioned segments:
1. Global Inhaler Market Research and Analysis, By Devices
2. Global Inhaler Market Research and Analysis, By Type
3. Global Inhaler Market Research and Analysis, By Applications
4. Global Inhaler Market Research and Analysis, By End Users

The Report Covers
  • Comprehensive research methodology of Global Inhaler market
  • This report also includes detailed and extensive market overview with key analyst insights.
  • Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the Global Inhaler
  • Insights about market determinants which are stimulating the Global Inhaler
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
Note: Product cover images may vary from those shown
2 of 3


  • 3M
  • Bespak
  • Glaxosmithkline
  • Midascare
  • Propeller Health
  • Teicos Pharma Ltd
  • MORE
1. Report Summary
1.1. Research Methods And Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders

2. Market Overview And Insights
2.1. Definition
2.2. Analyst Insights & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendation
2.2.3. Conclusion
2.3. Regulation United States European Union China India

3. Market Determinant
3.1. Motivators
3.1.1. Rising Number Of Smokers
3.1.2. Increase In Air Pollution
3.1.3. Prevalence Of Pulmonary Disease
3.1.4. Least Side Effects Compared To Other Alternatives
3.2. Restraint
3.2.1. High Cost Of Refill
3.2.2. Lifelong Nature Of Use
3.2.3. Risk Of Thrush Infection
3.3. Opportunity
3.3.1. Preference For Miniature And Compact Devices
3.3.2. Adoption Of Smart Inhalers

4. Market Segmentation
4.1. Global Inhaler Market, By Devices
4.1.1. Metered Dose Inhaler
4.1.2. Dry Powder Inhaler
4.1.3. Nebulizer Compression Nebulizer Ultrasonic Nebulizer
4.1.4. Nasal
4.2. Global Inhaler Market, By Type
4.2.1. Preventive Inhaler
4.2.2. Reliever Inhaler
4.2.3. Long Acting Bronchodilators Inhaler
4.3. Global Inhaler Market, By Applications
4.3.1. Asthma
4.3.2. Chronic Obstructive Pulmonary Disease
4.4. Global Inhaler Market, By End Users
4.4.1. Home Care
4.4.2. Hospitals & Clinics

5. Competitive Landscape
5.1. Key Strategies
5.2. Key Company Analysis

6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. Uk
6.2.2. Germany
6.2.3. Spain
6.2.4. France
6.2.5. Italy
6.2.6. Rest Of Europe
6.3. Apac
6.3.1. India
6.3.2. China
6.3.3. Japan
6.3.4. Rest Of Apac
6.4. Rest Of The World

7. Company Profiles
7.1. 3M
7.2. Agilent Technologies
7.3. Aradigm Corporation
7.4. Astrazeneca Plc
7.5. Bespak
7.6. Beximo Pharmaceuticals Ltd.
7.7. Boehringer Ingelheim Gmbh
7.8. Cipla Inc.
7.9. Drive Devilbiss Healthcare
7.10. Ge Healthcare
7.11. Glaxosmithkline
7.12. H&T Presspart Manufacturing Ltd
7.13. Hovione
7.14. Mannkind Corporation
7.15. Manta Devices Llc
7.16. Midascare
7.17. Novartis Ag
7.18. Omega Life Sciences
7.19. Omron Healthcare Europe B.V
7.20. Philips N.V
7.21. Propeller Health
7.22. Pulmatrix, Inc
7.23. Savara Inc
7.24. Spyryx Biosciences Inc
7.25. Teicos Pharma Ltd
7.26. Teijin Limited
7.27. Teva Respiratory Llc
7.28. Vitalograph
Note: Product cover images may vary from those shown
3 of 3


4 of 3
  • 3M
  • Agilent Technologies
  • Aradigm Corporation
  • Astrazeneca Plc
  • Bespak
  • Beximo Pharmaceuticals Ltd.
  • Boehringer Ingelheim Gmbh
  • Cipla Inc.
  • Drive Devilbiss Healthcare
  • Ge Healthcare
  • Glaxosmithkline
  • H&T Presspart Manufacturing Ltd
  • Hovione
  • Mannkind Corporation
  • Manta Devices Llc
  • Midascare
  • Novartis Ag
  • Omega Life Sciences
  • Omron Healthcare Europe B.V
  • Philips N.V
  • Propeller Health
  • Pulmatrix, Inc
  • Savara Inc
  • Spyryx Biosciences Inc
  • Teicos Pharma Ltd
  • Teijin Limited
  • Teva Respiratory Llc
  • Vitalograph
Note: Product cover images may vary from those shown